The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer.

[1]  J. Ricarte-Filho,et al.  Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension. , 2010, Thyroid : official journal of the American Thyroid Association.

[2]  I. Sugitani,et al.  Re-Evaluation of Histopathological Factors Affecting Prognosis of Differentiated Thyroid Carcinoma in an Iodine-Sufficient Country , 2010, World Journal of Surgery.

[3]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[4]  N. Bhattacharyya,et al.  Survival impact of treatment options for papillary microcarcinoma of the thyroid , 2009, The Laryngoscope.

[5]  J. Shah,et al.  Risk group stratification and prognostic factors in papillary carcinoma of thyroid , 1996, Annals of Surgical Oncology.

[6]  A. Miyauchi,et al.  Prognostic Significance of Extrathyroid Extension of Papillary Thyroid Carcinoma: Massive but Not Minimal Extension Affects the Relapse-free Survival , 2006, World Journal of Surgery.

[7]  A. Miyauchi,et al.  Minimal Extrathyroid Extension Does Not Affect the Relapse-Free Survival of Patients with Papillary Thyroid Carcinoma Measuring 4 cm or Less over the Age of 45 Years , 2005, Surgery Today.

[8]  C. Esselstyn,et al.  Conservative management of patients with intrathyroidal well-differentiated follicular thyroid carcinoma. , 2001, Surgery.

[9]  P. Ladenson,et al.  Prospective multicenter study of thyroid carcinoma treatment , 1998 .

[10]  P. Ladenson,et al.  Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. , 1998, Cancer.

[11]  J. Shah,et al.  Patterns of failure in differentiated carcinoma of the thyroid based on risk groups , 1998, Head & neck.

[12]  J. Shah,et al.  Differentiated carcinoma of the thyroid with extrathyroidal extension. , 1995, American journal of surgery.

[13]  S. Jhiang,et al.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.

[14]  E. Bergstralh,et al.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. , 1993, Surgery.

[15]  M. Kaplan,et al.  Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective. , 1990, Endocrinology and metabolism clinics of North America.

[16]  B. Cady,et al.  An expanded view of risk-group definition in differentiated thyroid carcinoma. , 1988, Surgery.

[17]  L. Woolner,et al.  Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. , 1986, Mayo Clinic proceedings.